title: Immunoglobulin A-associated lymphocytic vasculopathy: a clinicopathologic study of eight patients.
abstract: BACKGROUND
  Cutaneous IgA-associated vasculitis can be a clue to Henoch-Schönlein purpura (HSP), which typically comprises renal and gastrointestinal tract disease and arthritis, whereby prominent and predominant IgA deposits within the cutaneous vasculature provoke a pustular leukocytoclastic vasculitis.
  
  
  METHODS
  We describe eight patients with a novel expression of a cutaneous IgA vascular injury syndrome, namely a lymphoid vasculopathy which clinically and light microscopically resembled a pigmentary purpura (PP) in six, and correlate direct immunofluorescence (DIF) and clinical features to light microscopy.
  
  
  RESULTS
  Among associated diseases were prior viral infection, an HSP symptom complex, an undifferentiated connective tissue disease syndrome, lupus erythematosus profundus (LEP), Degos' disease and Berger's disease. Skin lesions comprised non-palpable petechial lesions involving lower extremities in all cases and also the upper extremities in two. A superficial perivascular lymphocytic infiltrate unaccompanied by vascular fibrin deposits was associated with prominent erythrocyte extravasation including into the epidermis. Mural and extravascular fibrin deposition was seen in one biopsy from a PP-like lesion and mural fibrinoid necrosis was seen in the cases of LEP and Degos' disease; in biopsies from these three cases, the presence of fibrin deposition warranted use of the appellation 'lymphocytic vasculitis'. In all patients, DIF showed prominent and predominant IgA deposits.
  
  
  CONCLUSIONS
  A non-necrotizing lymphocytic purpuric vascular reaction is one manifestation of vascular IgA deposition in the skin. A subpopulation of human lymphocytes bear surface Fc receptor and/or C3 receptors ('complement receptor lymphocytes') which can bind circulating immune complexes (ICs) or C3 generated via activation of the alternative complement cascade. Thus, circulating ICs are a potential pathogenic basis of this eruption, the histologic differential diagnosis of which is idiopathic PP and PP of drug or viral etiology.
authors.affiliation: Central Medical Laboratories, Winnipeg, Manitoba, Canada.
authors.forename: A Neil
authors.initials: AN
authors.lastname: Crowson
authors.forename: Cynthia M
authors.initials: CM
authors.lastname: Magro
authors.forename: Arif
authors.initials: A
authors.lastname: Usmani
authors.forename: N Scott
authors.initials: NS
authors.lastname: McNutt
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005121:Extremities / Q000473:pathology; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D006801:Humans; D011695:IgA Vasculitis / Q000378:metabolism* / Q000473:pathology; D007070:Immunoglobulin A / Q000378:metabolism*; D002479:Inclusion Bodies / Q000648:ultrastructure; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000378:metabolism* / Q000473:pathology
chemical_list: D007070:Immunoglobulin A